Agenda
- All
- February 3, 2025
- February 4, 2025
- February 5, 2025
February 3, 2025
9:00 a.m. - 7:00 p.m.
Registration
February 3, 2025
8:30 a.m. - 10:00 a.m.
Science and Regulatory Working Group (members only)
February 3, 2025
10:30 a.m. - 12:00 p.m.
Policy and WashRep Meeting (members only)
February 3, 2025
12:00 p.m. - 1:00 p.m.
Board Meeting Luncheon (by invitation only)
(members only)
February 3, 2025
1:00 p.m. – 4:00 p.m.
AAM Board of Directors Meeting (board members and invited guests only)
(board members and invited guests only)
February 3, 2025
5:00 p.m. - 6:00 p.m.
Access! 2025 Business Exposition Meet & Greet
(board members and invited guests only)
February 3, 2025
6:00 p.m. - 8:00 p.m.
Welcome Reception
(board members and invited guests only)
February 4, 2025
7:30 a.m. – 6:00 p.m.
Registration
February 4, 2025
7:30 a.m. - 8:30 a.m.
Networking Breakfast
February 4, 2025
8:30 a.m. – 8:45 a.m.
Welcome to Access! 2025
John Murphy III
President and CEO, AAM
February 4, 2025
8:45 a.m. – 9:00 a.m.
Access! Awards Presentation
2025 Champions of Access Award
February 4, 2025
9:00 a.m. – 9:30 a.m.
CDER Keynote Address
Jacqueline Corrigan-Curay, JD, M.D.
Principal Deputy Center Director, Center for Drug Evaluation and Research (CDER), FDA
February 4, 2025
9:30 a.m. - 10:00 a.m.
Networking Break
February 4, 2025
10:00 a.m. - 10:30 a.m.
The Future of Biosimilars Keynote
Murray Aitken
Executive Director, IQVIA Institute for Human Data Science
February 4, 2025
10:30 a.m. - 11:30 a.m.
What to Expect in the New Trump Administration
Alex Brill
Senior Fellow, American Enterprise Institute
Paul Heldman
Research Analyst, Health Policy, Nephron Research LLC
Dean Rosen
Partner, Mehlman Consulting
February 4, 2025
11:30 a.m. - 1:00 p.m.
Networking Luncheon
February 4, 2025
1:00 p.m. - 2:00 p.m.
Global and U.S. Generics and Biosimilars: Trends, Issues and Outlook
Doug Long
Vice President, Industry Relations, IQVIA
February 4, 2025
2:00 p.m. - 3:00 p.m.
What are the Changes Coming to Pharmacy
February 4, 2025
3:30 p.m. - 4:30 p.m.
Biosimilars Council Meeting (members only)
February 4, 2025
3:00 p.m. – 5:00 p.m.
Access! 2025 Business Exposition Hall
February 4, 2025
5:00 p.m. - 6:00 p.m.
Networking Reception
February 4, 2025
6:00 p.m. - 9:00 p.m.
Dinner & Entertainment
February 5, 2025
7:00 a.m. – 8:00 a.m.
Networking Breakfast
February 5, 2025
8:00 a.m. – 8:05 a.m.
Welcome to Day 2 Remarks
John Murphy III
President and CEO, AAM
February 5, 2025
8:05 a.m. – 8:30 a.m.
AAM Chair’s Address
February 5, 2025
8:30 a.m. – 8:40 a.m.
Lifetime Achievement Award
February 5, 2025
8:40 a.m. – 9:10 a.m.
Evolving Biosimilar Adoption Strategies
Joshua Fredell, PharmD
Vice President, PBM & Specialty Product Development, CVS Health
February 5, 2025
9:10 a.m. – 10:00 a.m.
Fireside Chat with Alex Azar
Alex Azar
Former Secretary, U.S. Department of Health and Human Services
Moderator: John Murphy III
President and CEO, AAM
February 5, 2025
10:00 a.m. – 10:30 a.m.
Networking Break
February 5, 2025
10:30 a.m. – 11:00 a.m.
Industry and Agency Challenges: The Perspective of a Former Commissioner
Scott Gottlieb, M.D.
Partner, New Enterprise Associates
Former Commissioner, FDA
February 5, 2025
11:00 a.m. – 12:15 p.m.
CEOs Unplugged
Moderator: Scott Gottlieb, M.D.
Partner, New Enterprise Associates
Former Commissioner, FDA
Pierluigi Antonelli
President & Chief Executive Officer, Fresenius Kabi
Vinita Gupta
Chief Executive Officer, Lupin
Chirag Patel
President and Co-Chief Executive Officer, Amneal Pharmaceuticals
February 5, 2025
12:15 p.m. – 12:30 p.m.
Closing Remarks
John Murphy III
President and CEO, AAM
February 5, 2025
12:30 p.m. – 1:30 p.m.
Access! 2025 Farewell Luncheon
February 5, 2025
1:30 p.m.
Access! 2025 Concludes
*Agenda is subject to change
